409 related articles for article (PubMed ID: 21762990)
1. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
Shields CL; Ramasubramanian A; Mellen PL; Shields JA
Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
3. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
[TBL] [Abstract][Full Text] [Related]
4. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
6. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
[TBL] [Abstract][Full Text] [Related]
10. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Kim BH; Kim MK; Wee WR; Oh JY
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
[TBL] [Abstract][Full Text] [Related]
12. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
13. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of conjunctival intraepithelial neoplasia in immunosuppressed patients].
Asada Y; Ohtomo K; Funaki T; Nakatani S; Ebihara N; Murakami A
Nippon Ganka Gakkai Zasshi; 2015 Apr; 119(4):259-65. PubMed ID: 25980045
[TBL] [Abstract][Full Text] [Related]
15. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Singh M; Gautam N; Kaur M
Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
17. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
Frucht-Pery J; Rozenman Y; Pe'er J
Ophthalmology; 2002 Mar; 109(3):548-52. PubMed ID: 11874760
[TBL] [Abstract][Full Text] [Related]
18. Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.
Char DH; Crawford JB
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):459-61. PubMed ID: 18193262
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
Kanaya R; Kase S; Ishijima K; Ishida S
In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
[TBL] [Abstract][Full Text] [Related]
20. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
